AU6330300A - Use of interleukin-6 in treatment of obesity and/or obesity associated disorders - Google Patents

Use of interleukin-6 in treatment of obesity and/or obesity associated disorders

Info

Publication number
AU6330300A
AU6330300A AU63303/00A AU6330300A AU6330300A AU 6330300 A AU6330300 A AU 6330300A AU 63303/00 A AU63303/00 A AU 63303/00A AU 6330300 A AU6330300 A AU 6330300A AU 6330300 A AU6330300 A AU 6330300A
Authority
AU
Australia
Prior art keywords
obesity
interleukin
treatment
associated disorders
obesity associated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU63303/00A
Inventor
John-Olov Jansson
Ville Wallenius
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sahltech i Goteborg AB
Original Assignee
Sahltech i Goteborg AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9902680A external-priority patent/SE9902680D0/en
Application filed by Sahltech i Goteborg AB filed Critical Sahltech i Goteborg AB
Publication of AU6330300A publication Critical patent/AU6330300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2264—Obesity-gene products, e.g. leptin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Child & Adolescent Psychology (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU63303/00A 1999-07-13 2000-07-13 Use of interleukin-6 in treatment of obesity and/or obesity associated disorders Abandoned AU6330300A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE9902680A SE9902680D0 (en) 1999-07-13 1999-07-13 Use of interleukin-6 in the treatment of obesity and disorders of blood fats
SE9902680 1999-07-13
SE9904424A SE9904424D0 (en) 1999-07-13 1999-12-03 Use of interleukin-6 in combination with leptin in the treatment of obesity
SE9904424 1999-12-03
PCT/SE2000/001491 WO2001003725A1 (en) 1999-07-13 2000-07-13 Use of interleukin-6 in treatment of obesity and/or obesity associated disorders

Publications (1)

Publication Number Publication Date
AU6330300A true AU6330300A (en) 2001-01-30

Family

ID=26663620

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63303/00A Abandoned AU6330300A (en) 1999-07-13 2000-07-13 Use of interleukin-6 in treatment of obesity and/or obesity associated disorders

Country Status (4)

Country Link
EP (1) EP1194159A1 (en)
AU (1) AU6330300A (en)
SE (1) SE9904424D0 (en)
WO (1) WO2001003725A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030129160A1 (en) * 2002-01-09 2003-07-10 John-Olov Jansson Use of Interleukin-6
SE0201689D0 (en) * 2002-06-03 2002-06-03 Sahltech Ab A method for identifying obese IL-6 responsive patients
CN101219208B (en) * 2005-01-04 2010-08-11 健能隆医药技术（上海）有限公司 Medicine use of interleukin-22
FR3080533A1 (en) 2018-04-27 2019-11-01 Enterosys USE OF IL-6 FOR THE TREATMENT OF DIABETES

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05186367A (en) * 1991-08-06 1993-07-27 Toray Ind Inc Therapeutic agent for hyperlipemia
HUP0000280A3 (en) * 1996-03-01 2002-09-30 Amgen Inc Thousand Oaks Canine ob protein compositions and methods

Also Published As

Publication number Publication date
EP1194159A1 (en) 2002-04-10
WO2001003725A1 (en) 2001-01-18
SE9904424D0 (en) 1999-12-03

Similar Documents

Publication Publication Date Title
AU3725997A (en) S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders
AU2001293553A1 (en) Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
IL187513A0 (en) Use of (s,s)-reboxetine in the treatment of pain conditions and incontinence
HUP0203367A3 (en) Benzylidine-thiazolidinediones and analogues and their use in the treatment of diabetes
AU6232899A (en) Use of transforming growth factor beta and growth factors in the treatment and prevention of diseases of the intestinal mucosa
HUP0401023A3 (en) Use of flibanserin in the treatment of sexual disorders
AU2003291609A1 (en) Cb 1/cb 2 receptor ligands and their use in the treatment of pain
AU4171500A (en) Flupirtine in the treatment of fibromyalgia and related conditions
IL149496A0 (en) Pharmaceutical combinations and their use in treating gastrointestinal disorders
AU7528001A (en) The use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
EP1416957A4 (en) Treatment of immune disorders and b cell disorders
AU2002252976A1 (en) Hydrazones and their therapeutic use
AU2300001A (en) Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease
AU2003286285A1 (en) Use of fgf-18 in the diagnosis and treatment of memory disorders
AU3099997A (en) The use of tcet in the prophylaxis and treatment of allergies
ZA97741B (en) Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders.
MXPA02000779A (en) Highly purified cytokine activating factor and methods of use.
PL352333A1 (en) Dihydrobenzodiazepines and use of same in treatment of dislipidemia
IL160018A0 (en) Isoxazolopyridinones and use thereof in the treatment of parkinson's disease
GB0128674D0 (en) Treatment of sleep disorders and the like
AU2001251306A1 (en) Treatment of sleep disorders with hypocretin-1
AU6330300A (en) Use of interleukin-6 in treatment of obesity and/or obesity associated disorders
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
AU2002210763A1 (en) Use of 1-ebio in the treatment of bipolar disorders
GB9903919D0 (en) Aminophenols and their therapeutic use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase